| Bunyaratavej N, Wajanavisit W, Pauvilai P, et al.
Safety and antisorptive power of Ibandronate applied in the real-life setting. [Journal Article, Research Support, Non-U.S. Gov't]
J Med Assoc Thai 2009 Sep.:S72-5.
Abstract | Full Citation | | Li M, Xing XP, Zhang ZL, et al.
Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study. [JOURNAL ARTICLE]
J Bone Miner Metab 2009 Oct 24.
Abstract | Full Citation | Find Related Articles | | Derman R, Kohles JD, Babbitt A
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment. [Journal Article]
Clin Interv Aging 2009.:357-65.
Abstract | Full Citation | Find Related Articles | | Boonen S, Kay R, Cooper C, et al.
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Oct 20.
Abstract | Full Citation | Find Related Articles | | Epstein S, Jeglitsch M, McCloskey E
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 16.
Abstract | Full Citation | Find Related Articles | | Pricey osteoporosis remedy doesn't beat older drugs. [Journal Article]
Consum Rep 2009 Aug; 74(8):19.
Full Citation | Find Related Articles | | Li JF, Yan JY
[Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head] [English Abstract, Journal Article]
Zhongguo Gu Shang 2009 Sep; 22(9):697-9.
Abstract | Full Citation | Find Related Articles | | Chung YS, Lim SK, Chung HY, et al.
Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women. [JOURNAL ARTICLE]
Calcif Tissue Int 2009 Oct 9.
Abstract | Full Citation | Find Related Articles | | Vahtsevanos K, Kyrgidis A, Verrou E, et al.
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw. [JOURNAL ARTICLE]
J Clin Oncol 2009 Oct 5.
Abstract | Full Citation | Find Related Articles | | Asche C, Nelson R, McAdam-Marx C, et al.
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. [JOURNAL ARTICLE]
Osteoporos Int 2009 Oct 2.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
